ENTITY
SMARTSCORE: 3.2/5
Celltrion Inc

Celltrion Inc (068270 KS)

610
Analysis
Health CareSouth Korea
Celltrion Inc. produces and sells biosimilar products and also provides consignm ent processing service for other companies. The Company's main product is Abata cept which is for arthritis treatment
more
01 Aug 2016 07:19

Alpha Generation & Share Buybacks in Korea

Korean companies are showing increasing willingness to buyback shares. Korea Stock Exchange announced that from beginning of this year to as of 27...

Logo
618 Views
Share
bearishCelltrion Inc
27 Jul 2016 20:55

Another Payer Speaks Cautiously

Leading U.S. pharmacy benefits manager Express Scripts (ESRX US) held a conference call today to discuss its Q2: 2016 results. The company is the...

Share
06 Jul 2016 16:13

SillaJen's December IPO: Valuation, Growth Expectation and IPO Timing

SillaJen Biotherapeutics (established in 2006) is indeed a rare breed in Korean pharmaceutical world. It is not a generic drug maker. It is not a...

Logo
3.5k Views
Share
05 Jul 2016 01:24

What the IPOs Completed in Korea Stock Exchange in 1H 2016 Reveal....

If you want to outperform the market, perhaps you should take a look at the IPO market in Korea. In the midst of difficult global IPO markets, the...

Logo
383 Views
Share
bearishCelltrion Inc
11 Jun 2016 19:20

Study Highlights Hurdles to U.S. Uptake of Inflectra

A new study (abstract attached) presented at the European Union League Against Rheumatism (EULAR) Conference highlights one of the main hurdles to...

Share
x